(Q46790161)

25 December 2017

title

Diagnosis and management of precocious puberty (English)

1 reference

25 December 2017

author name string

M D Wheeler

series ordinal

1

1 reference

25 December 2017

D M Styne

series ordinal

2

1 reference

25 December 2017

publication date

1 December 1990

1 reference

25 December 2017

Pediatric Clinics of North America

published in

1 reference

25 December 2017

volume

37

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

1255-1271

1 reference

25 December 2017

Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Linear growth as a function of age at onset of puberty and sex steroid dosage: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Premature menarche without other evidence of precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Gonadotropin-independent precocious puberty ("testotoxicosis"): influence of maturational status on response to ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Elevation of serum gonadotropins (LH and FSH) after releasing hormone (LH-RH) injection in normal children and in patients with disorders of puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Treatment of familial male precocious puberty with spironolactone and testolactone

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Variations in the Pattern of Pubertal Changes in Boys

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Variations in pattern of pubertal changes in girls

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Premature menarche: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Depot leuprolide acetate for treatment of precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Secretion of the adrenal androgen, dehydroepiandrosterone sulfate, during normal infancy, childhood, and adolescence, in sick infants, and in children with endocrinologic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Effect of Synthetic Luteinizing Hormone-Releasing Factor on Serum Testosterone and Gonadotropins in Prepubertal, Pubertal and Adult Males

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

Puberty without gonadotropins. A unique mechanism of sexual development

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

A prospective study of sexual development and growth in American girls: the statistics of menarchie

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2937010-9

7 January 2021

10.1016/S0031-3955(16)37010-9

Identifiers

DOI

0 references

1 reference

25 December 2017